GlaxoSmithKline bids adieu to vaccines president Luc Debruyne as executive overhaul continues
admin 12th June 2018 Uncategorised 0Luc Debruyne, who has served as GlaxoSmithKline’s president of vaccines for 5 years, will leave the company at the end of the year. More: GlaxoSmithKline bids adieu to vaccines president Luc Debruyne as executive overhaul continues Source: fierce
read more